Kerstin Casparij believes she and her City team-mates couldn't have given anymore in our Barclays Women's Super League draw with Everton. Despite a strong start from City, with an early goal from ...

Drugmaker Eli Lilly (LLY 3.78%) hasn't been exempt from the recent market pullback, but its stock shot higher following the announcement that its newest GLP-1 drug had successfully completed the ...

Nico O’Reilly and Mateo Kovacic scored the late goals that ensured a final victory at Goodison Park with the Toffees moving to Everton Stadium next season. It looked to be heading for a point apiece ...

In an April 10 press conference prior to the spring game, Coach Bell touched on the pros of Eli Holstein entering Year Two as opposed to battling the firehose of information a year earlier.

Horror director Eli Roth ain't done scaring the life outta you just yet -- he’s now inviting fans to make some killer investments and promising a terrifyingly good return. TMZ caught up with Eli ...

Giants fans surely don’t look back on cornerback Eli Apple’s tenure with New York very fondly. The 10th overall pick in the 2016 NFL Draft, solidly known as a draft bust amongst Giants fans ...

Exclusive: Creators Roth and Noah Belson celebrated the hidden gem's 25th anniversary with IndieWire. We’ve seen horror director Eli Roth split open skulls before, but the jack-of-many-trades ...

It's Thursday morning, 11:50 a.m. ET -- and Eli Lilly (NYSE: LLY) stock is off to the races! This morning, the Indianapolis-based pharmaceutical giant announced that its new GLP-1 weight loss pill ...

Eli Lilly stock surged as much as 17% after positive phase-three trial data came out for orforglipron. It found orforglipron, a GLP-1 weight-loss pill, led to significant weight and A1C reductions ...

Eli Lilly stock (NYSE: LLY) is gaining momentum on Thursday, April 17th, following the company’s announcement of successful results from the first of its late-stage trials for a daily obesity ...

Eli Lilly reported promising results from a study of its experimental oral drug that could rival popular injections to treat obesity and diabetes. By Rebecca Robbins and Gina Kolata Encouraging ...